Company profile ALLO
After 39 days of this quarter the interest is at 7.0. Based on that we can calculate that during remaining 52 days it will total up to 16.0. Allogene Therapeutics expected interest is significantly lower compared to previous quarter (-82.8%) and same quarter last year (-81.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 54 | 42 -22.2% QoQ | 67 59.5% QoQ | 61 -9.0% QoQ |
| 2020 | 186 244.4% YoY 204.9% QoQ | 119 183.3% YoY -36.0% QoQ | 64 -4.5% YoY -46.2% QoQ | 60 -1.6% YoY -6.2% QoQ |
| 2021 | 58 -68.8% YoY -3.3% QoQ | 74 -37.8% YoY 27.6% QoQ | 49 -23.4% YoY -33.8% QoQ | 78 30.0% YoY 59.2% QoQ |
| 2022 | 113 94.8% YoY 44.9% QoQ | 69 -6.8% YoY -38.9% QoQ | 52 6.1% YoY -24.6% QoQ | 68 -12.8% YoY 30.8% QoQ |
| 2023 | 85 -24.8% YoY 25.0% QoQ | 109 58.0% YoY 28.2% QoQ | 97 86.5% YoY -11.0% QoQ | 93 36.8% YoY -4.1% QoQ |
| 2024 | 7 -91.8% YoY -92.5% QoQ | - | - | - |
The average 5 years interest of Allogene Therapeutics was 6.15 per week. The last year interest of Allogene Therapeutics compared to the last 5 years has changed by 6.02%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 28.85%.
There is not enough data for Allogene Therapeutics UCART19 to provide analysis
There is not enough data for Allogene Therapeutics UCART19 to provide correlation calculation
There is not enough data for Allogene Therapeutics UCART19 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-501 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-501 to provide correlation calculation
There is not enough data for Allogene Therapeutics ALLO-501 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-501A to provide analysis
There is not enough data for Allogene Therapeutics ALLO-501A to provide correlation calculation
There is not enough data for Allogene Therapeutics ALLO-501A to provide analysis
There is not enough data for Allogene Therapeutics ALLO-715 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-715 to provide correlation calculation
There is not enough data for Allogene Therapeutics ALLO-715 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-605 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-605 to provide correlation calculation
There is not enough data for Allogene Therapeutics ALLO-605 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-647 to provide analysis
There is not enough data for Allogene Therapeutics ALLO-647 to provide correlation calculation
There is not enough data for Allogene Therapeutics ALLO-647 to provide analysis
There is not enough data for Allogene Therapeutics jobs to provide analysis
There is not enough data for Allogene Therapeutics jobs to provide correlation calculation
There is not enough data for Allogene Therapeutics jobs to provide analysis
There is not enough data for Allogene Therapeutics reviews to provide analysis
There is not enough data for Allogene Therapeutics reviews to provide correlation calculation
There is not enough data for Allogene Therapeutics reviews to provide analysis
After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0. Allogene Therapeutics -stock -company expected interest is significantly lower compared to previous quarter (-49.3%) and same quarter last year (-56.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 77 | 134 74.0% QoQ | 158 17.9% QoQ | 108 -31.6% QoQ |
| 2020 | 250 224.7% YoY 131.5% QoQ | 163 21.6% YoY -34.8% QoQ | 128 -19.0% YoY -21.5% QoQ | 56 -48.1% YoY -56.2% QoQ |
| 2021 | 129 -48.4% YoY 130.4% QoQ | 115 -29.4% YoY -10.9% QoQ | 105 -18.0% YoY -8.7% QoQ | 198 253.6% YoY 88.6% QoQ |
| 2022 | 202 56.6% YoY 2.0% QoQ | 160 39.1% YoY -20.8% QoQ | 114 8.6% YoY -28.8% QoQ | 131 -33.8% YoY 14.9% QoQ |
| 2023 | 159 -21.3% YoY 21.4% QoQ | 195 21.9% YoY 22.6% QoQ | 112 -1.8% YoY -42.6% QoQ | 138 5.3% YoY 23.2% QoQ |
| 2024 | 30 -81.1% YoY -78.3% QoQ | - | - | - |
The average 5 years interest of Allogene Therapeutics -stock -company was 10.97 per week. The last year interest of Allogene Therapeutics -stock -company compared to the last 5 years has changed by -3.19%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.61%.